HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma

PURPOSE: The identification of HER2 overexpression in a subset of gastric adenocarcinoma (GA) patients represents a significant step forward in unveiling the molecular complexity of this disease. The predictive and prognostic value of HER2 amplification in advanced HER2 inhibitor-treated GA patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zimin, Shi, Mingpeng, Li, Xiaoxiao, Song, Shanai, Liu, Ning, Du, Haiwei, Ye, Junyi, Li, Haiyan, Zhang, Zhou, Zhang, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021510/
https://www.ncbi.nlm.nih.gov/pubmed/33543328
http://dx.doi.org/10.1007/s00432-021-03522-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021510/
https://www.ncbi.nlm.nih.gov/pubmed/33543328
http://dx.doi.org/10.1007/s00432-021-03522-9

Ejemplares similares